IGKV2D-29 and drug-induced dyskinesia: Moreover, clinical trials have showed that oral administration A2A antagonists increase functional on-time duration in PD patients suffering from wearing-off phenomenon (less effective than DBS or l-dopa continuous infusion), although they may increase dyskinesia in patients with advanced PD (14).